October is National Depression Screening Month, and this series of posts will focus on identifying and understanding the palette of variation in major depressive disorder (MDD). In the United States, ...
Co-use of opioids and marijuana in patients with chronic illnesses increased risk of major depressive disorder compared with those using only one or the other or neither. Dirty Air: Is Depression ...
FiercePharma: J&J's Caplyta supersizes its reach with FDA nod as add-on treatment for major depressive disorder
J&J's Caplyta supersizes its reach with FDA nod as add-on treatment for major depressive disorder
Depressive symptoms are common in people with asthma, but increasing evidence suggests they may be driven by biological processes that differ from those seen in major depressive disorder.
Healio: Major depressive disorder linked to worse asthma outcomes among older adults
Please provide your email address to receive an email when new articles are posted on . Among 336 patients with asthma, 46 also had major depressive disorder. There were longitudinal associations ...
The novel serotonin norepinephrine reuptake inhibitor (SNRI) ammoxetine may effectively treat major depressive disorder (MDD) while avoiding some side effects common to other antidepressants, new ...
The American Journal of Managed Care: FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder